Boundless Bio retweeted
Today #CancerGrandChallenges team eDyNAmiC and their international collaborators published 3️⃣ papers in
@Nature 📣
They show the prevalence of ecDNA in cancer, identify fundamental mechanisms and an actionable target now being tested in the clinic.
More: bit.ly/4dUMU00
Boundless Bio retweeted
.@BoundlessBio is ringing in a $BOLD new chapter, celebrating its listing at the @NasdaqExchange Opening Bell! 🛎️🧬
At the intersection of science and technology, @BoundlessBio is a clinical-stage oncology company dedicated to addressing the significant unmet need of patients with oncogene amplified cancers through innovative research and therapies. Congratulations to the entire $BOLD team on this milestone. 🎉
Boundless Bio retweeted
Exciting potential for cancer therapy! Congrats to @BoundlessBio on the closing of their Series C financing co-led by @LeapsbyBayer.
We're excited about our investment in @BoundlessBio, a next-gen precision #oncology company developing innovative #ecDNA-directed therapies for patients with oncogene amplified #cancers, affecting up to 400,000 patients newly diagnosed in the US each year: bit.ly/41HuXvV
Boundless Bio - a next-gen precision oncology company
Boundless Bio retweeted
Targeting ‘Bond Villain’ DNA could be a new way to tackle aggressive cancers.
Congrats to Paul Mischel @mischellab and @Team_eDyNAmiC featured in @guardian for their brilliant work on #extrachromosomalDNA biology.
#CancerGrandChallenges #TeamScience
theguardian.com/science/2023…
Boundless Bio retweeted
We’re thrilled to share a partnership united in purpose: we’ve partnered with @BoundlessBio to accelerate #cancer drug #ClinicalTrial development #BreakingDataSilos #SOPHiNVESTORDAY
Boundless Bio retweeted

Forbes@Forbes17 Jun 2022
United States
United StatesConnected via WebAccount-level information, not a live location or per-post device.
The National Cancer Institute announced that four international research teams had been selected to receive a total of $100 million as part of the Cancer Grand Challenges program. trib.al/b0dGjhi
Boundless Bio retweeted
Yesterday, the @CancerGrand #CancerGrandChallenges program awarded $100 million to 4 interdisciplinary teams from around the world to solve some of the toughest challenges in #CancerResearch. Meet the teams today. cancergrandchallenges.org/
Boundless Bio retweeted
We are stronger together especially when solving cancers’ toughest challenges. That’s why today’s announcement of $100M from @NCI + @CR_UK to 4 innovative teams for Cancer Grand Challenges advances #CancerMoonshot goals. Cancer knows no boundaries — neither should we.
Announcing four new #CancerGrandChallenges teams, receiving a total of $100m to take on cancer’s toughest challenges
Congratulations to the new teams 🧵 1/n
@CR_UK @theNCI
Boundless Bio retweeted
Thank you to all the investigators from many academic cancer centers who contributed to this effort along with our industry collaborator @Mirati @ResBioscience @FoundationATCG @GuardantHealth @BoundlessBio
Boundless Bio retweeted
Boundless Bio nabs $105M for ecDNA-directed cancer therapy
@BoundlessBio
buff.ly/3nvpmpP
Boundless Bio retweeted
Cutting-edge Biotechs raise investors' hopes: @exscientiaAI and @BoundlessBio
#biotechnology #pharmaceuticals #lifesciences
hubs.li/H0M8FJC0
Boundless Bio retweeted
.@BoundlessBio’s research has uncovered a previously unknown driver of #cancer growth and drug resistance. With $105M in funding, the biotech is on a path to bring to the clinic small molecules that address this target, writes @frankvinluan @medcitynews medcitynews.com/2021/04/star…
Boundless Bio retweeted
Boundless Bio, pushing frontiers with ecDNA cancer therapy, raises $105m. By Sarah de Crescenzo. timmermanreport.com/2021/04/…
Boundless Bio retweeted
Boundless Bio CEO Zach Hornby and his team emerged today with a $105 million Series B led by Nextech Invest and RA Capital Management and plans to be in the clinic by 2023.
endpts.com/boundless-bio-rai…
Boundless Bio retweeted
Extrachromosomal DNA was once thought to be a rare event in cancer, but our group showed that ecDNA is very common indeed. —Paul Mischel, Stanford University bit.ly/3uDIwMF
Boundless Bio retweeted
Recently added to the speaker lineup:
@ZacharyHornby - @BoundlessBio CEO
Jayson Punwani - @TakedaPharma Ventures Senior Investment Director
#XconSD #XcelerateLS
Boundless Bio retweeted
$BBIO Boundless Bio takes big steps forward filling out their staff tinyurl.com/rpvng9b via @proactive_UK @BoundlessBio #BBIO






























